Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 12, Issue 4, 2011, Pages 469-474

  Ferri, Nicola ^a   Greco, Carolina Magdalen ^a   Maiocchi, Giuseppe ^b   Corsini, Alberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Novartis Farma SpA Medical Department   (Italy)

Author keywords

Angiotensinogen; collagen; PAI 1; prorenin; TGF

Indexed keywords

ALISKIREN; ANGIOTENSIN I; ANGIOTENSINOGEN; COLLAGEN TYPE 1; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRORENIN RECEPTOR; RENIN; TRANSFORMING GROWTH FACTOR BETA;

AORTA; ARTICLE; ATHEROGENESIS; CELL CULTURE; CELL SURFACE; DRUG EFFECT; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

AMIDES; ANGIOTENSIN I; ANGIOTENSINOGEN; AORTA; CELLS, CULTURED; FUMARATES; GENE EXPRESSION REGULATION; HUMANS; MYOCYTES, SMOOTH MUSCLE; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RENIN;

EID: 83455201547     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320311408751     Document Type: Article

References (26)

1. Gaddam KK, Oparil S. Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?. Curr Opin Nephrol Hypertens. 2008 ; 17: 484-490
2. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res. 1997 ; 80: 607-616 (Pubitemid 27181343)
3. Volpe M, Savoia C, De Paolis P, Ostrowska B, Tarasi D, Rubattu S. The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. J Am Soc Nephrol. 2002 ; 13: S173 - S178
4. Pimenta E, Oparil S. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?. Cardiol Clin. 2008 ; 26: 527-535
5. Rosendorff C. The renin-angiotensin system and vascular hypertrophy. J Am Coll Cardiol. 1996 ; 28: 803-812 (Pubitemid 26348140)
6. Gradman AH, Kad R. Renin inhibition in hypertension. J Am Coll Cardiol. 2008 ; 51: 519-528
7. Wood JM, Maibaum J, Rahuel J, et al. Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochem Biophys Res Commun. 2003 ; 308: 698-705 (Pubitemid 36976519)
8. Nussberger J, Aubert JF, Bouzourene K, Pellegrin M, Hayoz D, Mazzolai L. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension. 2008 ; 51: 1306-1311 (Pubitemid 351555942)
9. Ino J, Kojima C, Osaka M, Nitta K, Yoshida M. Dynamic observation of mechanically injured mouse femoral artery reveals an antiinflammatory effect of renin inhibitor. Arterioscler Thromb Vasc Biol. 2009 ; 29: 1858-1863
10. Lu H, Rateri DL, Feldman DL, et al. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest. 2008 ; 118: 984-993 (Pubitemid 351364606)
11. Cherney DZ, Lai V, Scholey JW, Miller JA, Zinman B, Reich HN. Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care. 33: 361-365
12. Feldman DL, Jin L, Xuan H, et al. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension. 2008 ; 52: 130-136
13. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002 ; 109: 1417-1427 (Pubitemid 34596167)
14. Nabi AH, Kageshima A, Uddin MN, Nakagawa T, Park EY, Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med. 2006 ; 18: 483-488
15. Batenburg WW, Krop M, Garrelds IM, et al. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens. 2007 ; 25: 2441-2453 (Pubitemid 350060383)
16. Feldt S, Batenburg WW, Mazak I, et al. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension. 2008 ; 51: 682-688 (Pubitemid 351301521)
17. Zhang J, Noble NA, Border WA, Owens RT, Huang Y. Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells. Am J Physiol Endocrinol Metab. 2008 ; 295: E810 - E819
18. Huang Y, Wongamorntham S, Kasting J, et al. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2006 ; 69: 105-113 (Pubitemid 43117745)
19. Rahuel J, Rasetti V, Maibaum J, et al. Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin. Chem Biol. 2000 ; 7: 493-504 (Pubitemid 30466984)
20. Ferri N, Roncalli E, Arnaboldi L, et al. Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol. 2009 ; 29: 1631-1637
21. Carey RM. Antihypertensive and renoprotective mechanisms of renin inhibition in diabetic rats. Hypertension. 2008 ; 52: 63-64
22. Schefe JH, Neumann C, Goebel M, et al. Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. J Hypertens. 2008 ; 26: 1787-1794
23. Brown MJ. Aliskiren. Circulation. 2008 ; 118: 773-784
24. Nguyen G, Delarue F, Berrou J, Rondeau E, Sraer JD. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 1996 ; 50: 1897-1903 (Pubitemid 26417532)
25. Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation. 2004 ; 110: 3849-3857 (Pubitemid 40023984)
26. Del Fiorentino A, Cianchetti S, Celi A, Pedrinelli R. Aliskiren, a renin inhibitor, downregulates TNF-alpha-induced tissue factor expression in HUVECS. J Renin Angiotensin Aldosterone Syst. 2010 ; 11: 243-247